64,

65.

66.

67.

68.

9.

To.

71.

72,

73.

7a.

75.

Raoult D. Full-length title: Early treatment of COVID-19 patients with hydroxychloroquine and azithromycin: A
retrospective analysis of 1061 cases in Marseille, France. Travel Med Infect Dis. May 2020:101738.
doi:10.1016/.tmaid.2020.101738.

Gendelman O, Amital H, Bragazzi NL, Watad A, Chodick G. Continuous hydroxychloroquine or colchicine
therapy does not prevent infection with SARS-CoV-2: Insights from a large healthcare database analysis.
Autoimmun Rev. May 2020:102566. doi:10.1016/) autrev.2020.102566.

Mathian A, Mahevas M, Rohmer J, Roumier M, Cohen-Aubart F, Amador-Borrero B, Barrelet A, Chauvet C,
Chazal T, Delahousse M, Devaux M, Euvrard R, Fadlallah J, Florens N, Haroche J, Hié M, Juillard L, Lhote R,
Maillet T, Richard-Colmant G, Palluy JB, Pha M, Perard L, Remy P, Rivigre E, Sêne D, Sêve P, Morélot-
Panzini C, Viallard J-F, Virot J-S, Benameur N, Zahr N, Yssel H, Godeau B, Amoura Z. Clinical course of
coronavirus disease 2019 (COVID-19) in a series of 17 patients with systemic lupus erythematosus under
long-term treatment with hydroxychloroquine. Ann Rheum Dis. April 2020. doi:10.1136/annrheumdis-2020-
217566.

Vastarella M, Patri A, Annunziata MC, Cantelli M, Nappa P, Tasso M, Costa L, Caso F, Fabbrocini G. Journal
Pre-proof Can hydroxychloroquine be useful in the prevention of COVID-19? An Italian survey in
dermatological and rheumatological patients already under treatment. J Am Acad Dermato!. 2020.
doi:10.1016/ jaad.2020.04.136.

Monti S, Balduzzi S, Delvino P, Bellis E, Quadrelli VS, Montecucco C. Clinical course of COVID-19 in a series
of patients with chronic arthritis treated with immunosuppressive targeted therapies. Ann Rheum Dis.
2020;79(5):667-668. doi:10.1136/annrheumdis-2020-217424.

Konig MF, Kim AH, Scheetz MH, Graef ER, Liew JW, Simard J, Machado PM, Gianfrancesco M, Yazdany J,
Langguth D, Robinson PC. Baseline use of hydroxychloroquine in systemic lupus erythematosus does not
preclude SARS-CoV-2 infection and severe COVID-19. Ann Rheum Dis. May 2020.
doi:10.1136/ANNRHEUMDIS-2020-217690.

Chen Z, Hu J, Zhang Z, Jiang S, Han S, Yan D, Zhuang R, Hu B, Zhang Z. Efficacy of hydroxychloroquine in
patients with COVID-19: results of a randomized clinical trial. medRxiv. April 2020:2020.03.22.20040758.
doi:10.1101/2020.03.22.20040758.

Carlucci PM, Ahuja T, Petrilli C, Rajagopalan H, Jones S, Rahimian J, Org JR. Hydroxychloroquine and
azithromycin plus zinc vs hydroxychloroquine and azithromycin alone: outcomes in hospitalized COVID-19
patients, doi:10.1101/2020.05.02.20080036.

Huang M, LiM, Xiao F, Liang J, Pang P, Tang T, Liu S, Chen B, Shu J, You Y, Li Y, Tang M, Zhou J, Jiang G,
Xiang J, Hong W, He S, Wang Z, Feng J, Lin C, Ye Y, Wu Z, Li Y, Zhong B, Sun R, Hong Z, Liu J, Chen H,
Wang X, Li Z, Pei D, Tian L, Xia J, Jiang S, Zhong N, Shan H. Preliminary evidence from a multicenter
prospective observational study of the safety and efficacy of chloroquine for the treatment of COVID-19.
medRxiv. May 2020:2020.04.26.20081059. doi:10.1101/2020.04.26.20081059.

Yu B, Wang DW, Li C. Hydroxychloroquine application is associated with a decreased mortality in critically ill
patients with COVID-19. medRxiv. May 2020:2020.04.27.20073379. doi:10.1101/2020.04.27.20073379.

Davido B, Lansaman T, Bessis S, Lawrence C, Alvarez J-C, Mascitti H, Bouchand F, Moine P, Perronne V,
Gal A Le, Annane D, Perronne C, Truchis P De, Team C-19 R. Hydroxychloroquine plus azithromycin: a
potential interest in reducing in-hospital morbidity due to COVID-19 pneumonia (HI-ZY-COVID)? medRxiv.
May 2020:2020.05.05.20088757. doi:10.1101/2020.05.05.20088757.

Barbosa Esper R, Souza da Silva R, Teiichi Costa Oikawa F, Machado Castro M, Razuk-Filho A, Benedito
Batista Junior P, Wilhelm Lotze S, Nunes da Rocha C, de Sá Cunha Filho R, Emanuel Barbosa de Oliveira S,
Leitão Ribeiro P, Cristina Vigar Martins V, Silva Braga Bueno F, Ligeiro Gonçalves Esper P, Fagundes
Parrillo E. Empirica! Treatment with Hydroxychloroquine and Azithromycin for Suspected Cases of COVID-19
Followed-up by Telemedicine.

Novales FJM de, Ramírez-Olivencia G, Estébanez M, Dios B de, Herrero MD, Mata T, Borobia AM, Gutiérrez
C, Simón M, Ochoa A, Martínez Y, Aguirre A, Alcântara F de A, Fernández-González P, López E, Campos S,
Navarro M, Ballester LE. Early Hydroxychloroquine Is Associated with an Increase of Survival in COVID-19
Patients: An Observational Study. May 2020. doi:10.20944/PREPRINTS202005.0057.V1.
